- Home
- VEEE vs MYNZ Comparison
VEEE vs MYNZ Comparison
Compare VEEE & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- MYNZ
- Stock Information
- Founded
- VEEE 1994
- MYNZ 2021
- Country
- VEEE United States
- MYNZ Germany
- Employees
- VEEE N/A
- MYNZ N/A
- Industry
- VEEE Marine Transportation
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- MYNZ Health Care
- Exchange
- VEEE Nasdaq
- MYNZ Nasdaq
- Market Cap
- VEEE 6.4M
- MYNZ 5.5M
- IPO Year
- VEEE 2021
- MYNZ 2021
- Fundamental
- Price
- VEEE $2.18
- MYNZ $1.37
- Analyst Decision
- VEEE
- MYNZ Buy
- Analyst Count
- VEEE 0
- MYNZ 2
- Target Price
- VEEE N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- VEEE 851.0K
- MYNZ 118.7K
- Earning Date
- VEEE 08-13-2025
- MYNZ 07-07-2025
- Dividend Yield
- VEEE N/A
- MYNZ N/A
- EPS Growth
- VEEE N/A
- MYNZ N/A
- EPS
- VEEE N/A
- MYNZ N/A
- Revenue
- VEEE $12,724,465.00
- MYNZ $893,991.00
- Revenue This Year
- VEEE N/A
- MYNZ $26.06
- Revenue Next Year
- VEEE N/A
- MYNZ $4.97
- P/E Ratio
- VEEE N/A
- MYNZ N/A
- Revenue Growth
- VEEE N/A
- MYNZ N/A
- 52 Week Low
- VEEE $2.05
- MYNZ $1.34
- 52 Week High
- VEEE $9.30
- MYNZ $22.40
- Technical
- Relative Strength Index (RSI)
- VEEE 45.45
- MYNZ 23.25
- Support Level
- VEEE $2.06
- MYNZ $1.34
- Resistance Level
- VEEE $2.34
- MYNZ $1.48
- Average True Range (ATR)
- VEEE 0.15
- MYNZ 0.13
- MACD
- VEEE 0.02
- MYNZ -0.01
- Stochastic Oscillator
- VEEE 33.03
- MYNZ 3.72
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.